{
  "version": "1.2.0",
  "chapters": [
    {
      "title": "Welcome to In-Orbit",
      "startTime": 0,
      "endTime": 33
    },
    {
      "title": "Meet the Experts: Martin and William",
      "startTime": 33,
      "endTime": 209
    },
    {
      "title": "Understanding Microgravity",
      "startTime": 209,
      "endTime": 386
    },
    {
      "title": "Microgravity's Impact on the Human Body",
      "startTime": 386,
      "endTime": 527
    },
    {
      "title": "Crystals and Drug Design in Space",
      "startTime": 527,
      "endTime": 976
    },
    {
      "title": "The Future of Pharmaceuticals in Space",
      "startTime": 976,
      "endTime": 1061
    },
    {
      "title": "Introduction to Space Drug Development",
      "startTime": 1061,
      "endTime": 1072
    },
    {
      "title": "Experiments and Companies in Space",
      "startTime": 1072,
      "endTime": 1203
    },
    {
      "title": "Challenges and Regulatory Hurdles",
      "startTime": 1203,
      "endTime": 1295
    },
    {
      "title": "Bone Loss and Osteoporosis Drugs",
      "startTime": 1295,
      "endTime": 1730
    },
    {
      "title": "3D Bioprinting and Future Prospects",
      "startTime": 1730,
      "endTime": 1947
    },
    {
      "title": "Investment and Future of Space Medicine",
      "startTime": 1947,
      "endTime": 2338
    }
  ]
}